2Hund E, Genzwürker H, Bohrer H, et at. Predominant involvement of motor fibres in patients with critical illness polyneuropathy. Br J Anaesth, 1997,78(3 ):274-278.
3Witt N J, Zochodne DW, Bolton CF, et al. Peripheral nerve function in sepsis and multiple organ failure. Chest, 1991,99( 1 ):176-184.
4Bolton CF. Sepsis and the systemic inflammatory response syndrome:neuromuscular manifestations. Criti Care Med, 1996,24(8): 1408-1416.
5Fenzi F, Latronico N, Refatti N, et al. Ehanced expression of E-selectin on the vascular endothelium of peripheral nerve in critically ill patients with neuromuscular disorders. Acre Neuropathol (Berl) ,2003, 106( 1 ) : 75-82.
6Van den Berg, he G,Schoonheydt K,Beex P,et al. Insulin therapy protects the central and peripheral nervous system of intensive care patients. Neurology, 2005,64( 8 ) : 1348-1353.
7Galassi G, Ferrari S,Cobelli M,et al.Neuromuscular complications of kidney diseases. Nephrol Dial Transplant, 1998,7::41-47.
9Trojaborg W,Weimer LH,Hays AP.Electrophysiologic studies in critical illness associated weakness:myopathy or neuropathy——a reappraisal.Clin Neurophysiol, 2001,112( 9 ) : 1586-1593.
10Nicola L, Peli E, Botteri M. Critical illness myopathy and neuropathy.Curr Opin Crit Care,2005,11:126-132.
二级参考文献4
1Tadros T,Traber DL,Heggers JP, Effects of interleukin - 1α administration on intestinal ischemia and reperfusion injury , mucosal permeability, and bacterial translocation in burn and sepsis. Ann Surg,2003,237(1) : 101 - 109.
